You are here
- Home
- Media
- Press releases
- 2000
ASTRAZENECA TO OUTSOURCE GLOBAL IT INFRASTRUCTURE SERVICES TO IBM
- Reference code :
- wf352
- Published date :
-
26 October 2000
- Expired date :
-
13 March 2028
AstraZeneca today announced that it has identified IBM as its preferred supplier of global Information Technology (IT) infrastructure services. This is subject to signature of a contract, the key terms of which have already been established in principle with IBM. A further announcement will be made once a contract has been signed.
Some 1200 people worldwide (AstraZeneca employees and contract staff) are currently engaged in the provision of IT infrastructure services to AstraZeneca. All "in-scope" AstraZeneca employees will be offered employment by IBM and detailed consultations are commencing with employees and their representatives.
Jon Symonds, Chief Financial Officer of AstraZeneca, said, "This partnership will enable AZ to sharpen the focus of its Information Services (IS) capabilities on to the strategic opportunities such as e-business and informatics in R&D, and further encourage added value from IS activities. Once finalised, the partnership will give AZ enhanced technical power and provide better opportunities for personal development for these IT professionals, as well as significant cost savings."
Frank Kern, General Manager, Professional Services, IBM Global Services, said, "We are extremely pleased to have been selected by AstraZeneca as the preferred supplier to outsource their IT infrastructure on a global basis.
AstraZeneca is a leading pharmaceutical company, with extensive research capabilities, operating around the globe. We recognise the critical importance of a robust IT infrastructure to support their business, and how this partnership can help AstraZeneca focus on strategic IS opportunities."
Note to News Editors:
ABOUT ASTRAZENECA
AstraZeneca is a major international healthcare business engaged in the research, development, manufacture and marketing of ethical (prescription) pharmaceuticals and the supply of healthcare services. It is one of the top five pharmaceutical companies in the world with healthcare sales of over $15 billion and leading positions in sales of gastrointestinal, oncology, anaesthesia including pain management, cardiovascular, central nervous system (CNS) and respiratory products.
ABOUT IBM
IBM is the world's largest information technology company, with 80 years of leadership in helping businesses innovate. IBM offers a wide range of services, solutions and technologies that enable companies to take full advantage of the new era of e-business. IBM Global Services is the world's largest information technology services provider, with 1999 revenues of more than $32 billion.
Services is the fastest growing part of IBM, with more than 138,000 professionals serving customers in 160 countries. IBM Global Services integrates IBM's broad range of capabilities - services, hardware, software and research - to help companies of all sizes realise the full value of information technology.
For more information on IBM, visit www.ibm.com.
Further enquires to:
AstraZenecaChris Major +44 (0)20 7304 5028 Lucy Williams +44 (0)20 7304 5034 |
IBMLorna Campbell +44 (0)1844 338145 |
Not signed in
Page tools
Page tools
Share price
- London
-
26.95 GBP - New York
-
44.82 USD - Stockholm
-
310.10 SEK
At 21-Nov-2009 10:43 GMT
Detailed share priceIntroduction to AstraZeneca
Our responsibility
We continue to communicate openly on a range of issues, including:
Contact us
Stay in touch
Introduction to AstraZeneca
Our responsibility
We continue to communicate openly on a range of issues, including:
